PHARMACEUTICAL FORMULATIONS OF AN ANDROGEN RECEPTOR-TARGETED PROTEIN DEGRADER
AR135816A1Pending Publication Date: 2026-10-28ARVINAS OPERATIONS INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250101094
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-04-25
- Filing Date
- 2025-04-25
- Publication Date
- 2026-10-28
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
The present invention relates to formulations of Compound (A) or one of its pharmaceutically acceptable salts. The present invention also relates to methods of manufacturing such formulations and their uses in the treatment of prostate cancer.